LOOK: The Volume on (PETV) is 16X Greater - 600k vs 37k Daily - Stock Surges 30%

WOW! See the Volume of (PETV) its 600k Now Clobbering its normal 37k a Day HUGE Volume Breakout Happening Now in PetVivo Inc. (NASDAQ: PETV) 600k In Volume Right Now Clobbering Its Normal 37k A Day Average Stock Surging Strong Up 30%! 10XProTrader Member, Kevin Vander here with a critical Volume update! Shares of PetVivo Inc. (NASDAQ: PETV) are exploding right now to the tune of 600,000 shares traded BEFORE lunch! The stock usually trades 37,000 a DAY.... You need to pay close attention to (PETV) because its totally disrupting the entire small-cap market this morning. The Volume is 16X greater than usual! This is a key indicator and bullish sign that (PETV) current surging gain of 30% could drastically increase as the day presses on. New Premium Alert (NASDAQ: PETV) Has 450% Upside This $.87 Biomedical Stock Has [$5.00 Analyst Price Target!]( PETV shares could sky-rocket based on Wall Streets most respected publication, CNN Markets mentions Analyst 12-month target price of $5.00/shr. Interested in a stock that has a staggering [450% upside]( according to analyst Interested in a stock that a majority of the ["Insiders"]( are buying their own stock? When you come across a stock that has heavy insider buying, you need to stop and think to yourself. Do they know something that YOU don't know? [See Here]( PetVivo Inc. (NASDAQ: PETV) is based in Minneapolis, Minnesota. It is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. PetVivo believes that it can leverage the investments in the human bio-materials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. PetVivo's strategy is to in-license proprietary products from human medical device companies specifically for use in pets. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than the more stringently regulated pharmaceuticals. PetVivo Inc. (NASDAQ: PETV) Business Description The Company is primarily engaged in the business of commercializing and licensing products in the veterinary market to treat and/or manage afflictions of companion animals such as dogs and horses. Most of our technology was developed for human biomedical applications, and we intend to leverage the investments already expended in their development to commercialize treatments for horses and companion animals in a capital and time-efficient way. Many of the Company’s products are derived from proprietary biomaterials that simulate a body’s cellular tissue by virtue of their reliance upon natural protein and carbohydrate compositions which incorporate such “tissue building blocks” as collagen, elastin, and proteoglycans such as heparin. Since these are naturally-occurring in the body, we believe they have an enhanced biocompatibility with living tissues compared to synthetic biomaterials such as those based upon alpha-hydroxy polymers (e.g PLA, PLGA, and the like), polyacrylamides, and other “natural” biomaterials that may lack the multiple proteins incorporated into our biomaterials. The Company has several bullish catalysts in the pipeline and is on the verge of disrupting a $11 Bln space and has been making major strides with blockbuster product pipeline and intellectual property portfolio producing a strong catalyst for incredible upside potential! Conclusion: Between the [analyst price target]( being a staggering 450% higher than the current price, and the heavy [insider buying]( happening, I'm extremely bullish on (NASDAQ: PETV). I am urging all of our 10X members to add (NASDAQ: PETV) to the top of your watch list right now! 10X Your Wealth, Kevin Vander Publisher, 10XProTrader.com Investment Research You are receiving this e-mail as part of your subscription to 10XProTrader. Please do not reply to this e-mail as this address is not monitored. Our Customer Service team is available Monday - Friday between 9:00 AM and 5:00 PM ET. © 2023 10XProTrader.com. All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular inves∙tment situation. N∙o communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers, prior or during our reporting on the company. © 2023 10XProTrader.com, All Rights Reserved. 10XProTrader is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or inve∙stment for any specific individual. This communication is a paid a∙dvertisement. 10XProTrader.com and/or its subsidiaries and/or affiliates ("Company," "we," or "us") have been compensated $20,000 USD to disseminate information. Please note that we do not trade any securities that we profile. We do not hold positions in stocks we profile. We do not except stock as a form of payment for our profiles. Please review the full disc∙laimer at [( for important information about this advertisement. © 2023 10XProTrader. All rights reserved., 340 Royal Poinciana Way Suite 317, 33480, Palm Beach, United States You may [unsubscribe]( or [change your contact details]( at any time.